HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Paul R. Vogt Mario L. Lachat Marko I. Turina Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Schönbeck, M. H. Articles by Turina, M. I. Search for Related Content PubMed PubMed Citation Articles by Schönbeck, M. H. Articles by Turina, M. I.

Ann Thorac Surg 1998;65:1207-1214
© 1998 The Society of Thoracic Surgeons

Long-Term Follow-up in Hypertrophic Obstructive Cardiomyopathy After Septal Myectomy

^a Clinic of Cardiovascular Surgery, Department of Surgery, University Hospital, Zurich, Switzerland
^b Division of Cardiology, Department of Medicine, University Hospital, Zurich, Switzerland

Address reprint requests to Dr Schönbeck, Clinic of Cardiovascular Surgery, University Hospital, Raemistrasse 100, CH-8091 Zurich, Switzerland

Presented at the Thirty-third Annual Meeting of The Society of Thoracic Surgeon, San Diego, CA, Feb 3–5, 1997.

Background. Controversy exists about the choice of treatment for patients with hypertrophic obstructive cardiomyopathy. The purpose of this study was to evaluate clinical and echocardiographic long-term results in patients with hypertrophic obstructive cardiomyopathy after septal myectomy and to determine predictors of event-free survival in these patients.

Methods. Between 1965 and 1995, 110 consecutive patients 2 to 66 years old (mean age, 37 ± 15 years) with an invasively measured left ventricular outflow tract gradient of 86 ± 39 mm Hg (81 ± 42 mm Hg by Doppler echocardiography) underwent either septal myectomy only (n = 87) or myectomy combined with additional procedures (n = 23). Mean follow-up was 11.7 ± 7.5 years. Predictors of late events were calculated using multivariate Cox regression analysis.

Results. The perioperative mortality rate was 3.6% (n = 4). The cumulative survival rate at 5, 10, and 15 years was 93%, 80%, and 72%, respectively, and symptom-free survival, 77%, 50%, and 33%, respectively. Predictors of late death were New York Heart Association class III or IV (p < 0.05), congestive heart failure (p < 0.05) and additional procedures (p < 0.05). The left ventricular outflow tract gradient was nearly eliminated in all patients, the left atrial dimension decreased significantly during the early years, and left ventricular dilatation occurred late in 17 patients.

Conclusions. Septal myectomy is associated with a low perioperative mortality and a high late survival rate (72% at 15 years’ follow-up). Septal myectomy is still an excellent modality in the treatment strategy for symptomatic patients with hypertrophic obstructive cardiomyopathy.